glp-1 dementia glp1 #diabetes #sglt2 #dementia #alzheimer | Robert Gabbay MD, PhD CKD Dementia Risk Reduced with

Strengths: Highest documented bioavailability Dose delivery is reliable and predictable Compatible with published dosing protocols Well-documented safety profile Limitations: Requires patient willingness and capability for self-injection Needles, disposal, and injection-site considerations Requires refrigerated storage for most preparations Oral Spray: A Growing Alternative Oral spray formulations deliver peptide into the oral cavity, with absorption occurring through the oral mucosa and variably through ingestion with subsequent partial degradation

Referral to a registered dietitian is appropriate for patients with significant fatigue, rapid weight loss (more than 1-2% body weight per week), or concerns about nutritional adequacy

Consequently, therapeutic strategies targeting PRRs primarily involve the use of ligand analogs to activate these receptors, 577 using antagonists to block their activation, or using antibodies and small molecules to inhibit PRR signaling pathways

Hexarelin, a hexapeptide with the primary sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, is a chemically modified derivative of GHRP-6